These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23993459)

  • 1. Letter to the editor regarding response to manuscript entitled: completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol. 2013 Jun;39(6):601-7.
    Grabau D
    Eur J Surg Oncol; 2013 Nov; 39(11):1296-7. PubMed ID: 23993459
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding manuscript entitled: completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol. 2013 Jun;39(6):601-7.
    Kirwan CC; Debnath D; Howe MC; Johnson RK; Bundred NJ
    Eur J Surg Oncol; 2013 Nov; 39(11):1294-5. PubMed ID: 24007836
    [No Abstract]   [Full Text] [Related]  

  • 3. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
    Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
    Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micrometastatic sentinel lymph node disease: do patients benefit or suffer harm from axillary lymph node dissection?
    Ziogas D; Zografos GC
    Ann Surg Oncol; 2010 Mar; 17(3):936-7; author reply 938. PubMed ID: 19937389
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
    J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Another variable in lymph node biopsy.
    Rogers LW; Ries SG
    Am J Clin Pathol; 2000 Aug; 114(2):293-5. PubMed ID: 10941348
    [No Abstract]   [Full Text] [Related]  

  • 14. A logistic regression model predicting high axillary tumour burden in early breast cancer patients.
    Barco I; García Font M; García-Fernández A; Giménez N; Fraile M; Lain JM; Vallejo E; González S; Canales L; Deu J; Vidal MC; Rodríguez-Carballeira M; Pessarrodona A; Chabrera C
    Clin Transl Oncol; 2017 Nov; 19(11):1393-1399. PubMed ID: 28808943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does predicting positive nonsentinel nodes answer the question of axillary dissection and provide a benefit?
    Slomski C; Julian TB
    J Natl Cancer Inst; 2012 Dec; 104(24):1858-9. PubMed ID: 23221924
    [No Abstract]   [Full Text] [Related]  

  • 16. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
    Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
    Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False negative sentinel node procedure established through palpation of the biopsy wound.
    Tanis PJ; Nieweg OE; Merkus JW; Peterse JL; Kroon BB
    Eur J Surg Oncol; 2000 Nov; 26(7):714-5. PubMed ID: 11078620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
    Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
    Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.